Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles

Classical targeting in cancer focuses on the development of chemical structures able to bind to protein pockets with enzymatic activity. Some of these molecules are designed to bind the ATP side of the kinase domain avoiding protein activation and the subsequent oncogenic activity. A further improve...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Alberto Juan, María del Mar Noblejas-López, María Arenas-Moreira, Carlos Alonso-Moreno, Alberto Ocaña
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2022-02-01
Saila:	Frontiers in Cell and Developmental Biology
Gaiak:	PROTACs technology drug delivery systems nanomedicine polymeric nanoparticles lipid-based nanoparticles metallic nanoparticles
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fcell.2021.805336/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!